1. An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare

   • Marc A. Koopmanschap
   • N. Job A. van Exel
   • Werner B. F. Brouwer

   Practical Application 22 September 2012 Pages: 269 - 280

   

2. Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions

   • Sanjoy Roy
   • S. Suresh Madhavan

   Review Article 22 September 2012 Pages: 281 - 296

   

3. The Use of QALY Weights for QALY Calculations

   • Paul A. Scuffham
   • Jennifer A. Whitty
   • Rosalie Viney

   Original Research Article 22 September 2012 Pages: 297 - 310

   

4. Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis

   • Simon Kreck
   • Jochen Klaus
   • Hans-Helmut König

   Original Research Article 22 September 2012 Pages: 311 - 328

   

5. An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes

   • Scott D. Ramsey
   • Lauren D. Clarke
   • Larry Z. Liu

   Original Research Article 22 September 2012 Pages: 329 - 339

   

6. Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study

   • Martin Knapp
   • Frank Windmeijer
   • Diego Novick

   Original Research Article 22 September 2012 Pages: 341 - 358